Data / Drug companies / KVK-Tech, Inc.
KVK-Tech, Inc.: 71 products in the FDA NDC directory, labeler code 10702
KVK-Tech, Inc. (labeler code 10702) lists 71 products in the FDA National Drug Code Directory, covering 29 finished drugs by generic name. By type: 70 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on March 1, 2024.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 10702
- Products in commercial distribution
- 71
- Packages
- 171
- Finished drugs by generic name
- 29
- Prescription products
- 70
- Over the counter products
- 1
- Controlled substance products
- Schedule II 35, Schedule III 5, Schedule IV 8
- Flagged as original packager
- 71 of 71 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 31, 2006
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 70 | 98.6% |
| Authorized generics (NDA) | 1 | 1.4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 70 | 98.6% |
| Over the counter drugs | 1 | 1.4% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 45 | 63.4% |
| Capsule | 6 | 8.5% |
| Tablet, film coated | 5 | 7% |
| Solution | 5 | 7% |
| Tablet, coated | 2 | 2.8% |
| Capsule, extended release | 1 | 1.4% |
| Powder | 1 | 1.4% |
| Suspension | 1 | 1.4% |
| Emulsion | 1 | 1.4% |
| Tablet, film coated, extended release | 1 | 1.4% |
| Liquid | 1 | 1.4% |
| Injection, solution | 1 | 1.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Carmustine | 10702-361 | Kit | Generic drugs (ANDA) | March 1, 2024 |
| Isoproterenol hydrochloride | 10702-364 | Injection, solution | Generic drugs (ANDA) | September 25, 2023 |
| Cyclosporine | 10702-808 | Emulsion | Authorized generics (NDA) | February 10, 2022 |
| Leflunomide | 10702-278 | Tablet | Generic drugs (ANDA) | July 23, 2020 |
| Leflunomide | 10702-277 | Tablet | Generic drugs (ANDA) | July 23, 2020 |
| Oxycodone and acetaminophen | 10702-238 | Solution | Generic drugs (ANDA) | December 5, 2019 |
| Atovaquone Oral Suspension | 10702-223 | Suspension | Generic drugs (ANDA) | March 29, 2019 |
| Desmopressin Acetate | 10702-170 | Tablet | Generic drugs (ANDA) | January 28, 2019 |
| Desmopressin Acetate | 10702-169 | Tablet | Generic drugs (ANDA) | January 28, 2019 |
| Butalbital, Acetaminophen and Caffeine | 10702-253 | Tablet | Generic drugs (ANDA) | September 26, 2018 |
| Ursodiol | 10702-237 | Capsule | Generic drugs (ANDA) | May 17, 2018 |
| Phentermine Hydrochloride | 10702-067 | Tablet | Generic drugs (ANDA) | March 29, 2018 |
| Oxycodone and Acetaminophen | 10702-187 | Tablet | Generic drugs (ANDA) | February 9, 2018 |
| Oxycodone and Acetaminophen | 10702-186 | Tablet | Generic drugs (ANDA) | February 9, 2018 |
| Oxycodone and Acetaminophen | 10702-185 | Tablet | Generic drugs (ANDA) | February 9, 2018 |
| Oxycodone and Acetaminophen | 10702-184 | Tablet | Generic drugs (ANDA) | February 9, 2018 |
| Oxybutynin Chloride | 10702-201 | Tablet | Generic drugs (ANDA) | December 22, 2017 |
| Hydrocodone Bitartrate and Homatropine Methylbromide | 10702-055 | Tablet | Generic drugs (ANDA) | August 7, 2017 |
| Oxycodone Hydrochloride | 10702-183 | Solution | Generic drugs (ANDA) | July 21, 2017 |
| Oxycodone hydrochloride | 10702-171 | Solution | Generic drugs (ANDA) | July 21, 2017 |
| Hydrocodone Bitartrate and Acetaminophen | 10702-194 | Tablet | Generic drugs (ANDA) | June 22, 2017 |
| Hydrocodone Bitartrate and Acetaminophen | 10702-193 | Tablet | Generic drugs (ANDA) | June 22, 2017 |
| Hydrocodone Bitartrate and Acetaminophen | 10702-192 | Tablet | Generic drugs (ANDA) | June 22, 2017 |
| Hydrocodone Bitartrate and Acetaminophen | 10702-191 | Tablet | Generic drugs (ANDA) | June 22, 2017 |
| Hydrocodone Bitartrate and Acetaminophen | 10702-190 | Tablet | Generic drugs (ANDA) | June 22, 2017 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.